TWI295671B - Tricyclic tetrahydroquinoline antibacterial agents - Google Patents

Tricyclic tetrahydroquinoline antibacterial agents Download PDF

Info

Publication number
TWI295671B
TWI295671B TW092127679A TW92127679A TWI295671B TW I295671 B TWI295671 B TW I295671B TW 092127679 A TW092127679 A TW 092127679A TW 92127679 A TW92127679 A TW 92127679A TW I295671 B TWI295671 B TW I295671B
Authority
TW
Taiwan
Prior art keywords
pyrimidine
tetrahydro
trione
dimethyl
porphyrin
Prior art date
Application number
TW092127679A
Other languages
English (en)
Chinese (zh)
Other versions
TW200413394A (en
Inventor
Robert Barbachyn Michael
Joseph Dobrowolski Paul
Ross Hurd Alexander
Joseph Mcnamara Dennis
Raymond Palmer John
Glenn Romero Arthur
Craig Ruble James
Ann Sherry Debra
Marie Thomasco Lisa
Laurence Toogood Peter
Gordon L Bundy
Gary E Martin
Donna L Romero
Original Assignee
Pharmacia & Upjohn Co Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmacia & Upjohn Co Llc filed Critical Pharmacia & Upjohn Co Llc
Publication of TW200413394A publication Critical patent/TW200413394A/zh
Application granted granted Critical
Publication of TWI295671B publication Critical patent/TWI295671B/zh

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/12Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
    • C07D471/20Spiro-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/04Anorexiants; Antiobesity agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D498/00Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/02Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D498/10Spiro-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D498/00Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/12Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
    • C07D498/20Spiro-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Child & Adolescent Psychology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
TW092127679A 2002-10-07 2003-10-06 Tricyclic tetrahydroquinoline antibacterial agents TWI295671B (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US41668502P 2002-10-07 2002-10-07
US42718902P 2002-11-18 2002-11-18
US45762203P 2003-03-26 2003-03-26

Publications (2)

Publication Number Publication Date
TW200413394A TW200413394A (en) 2004-08-01
TWI295671B true TWI295671B (en) 2008-04-11

Family

ID=32074379

Family Applications (1)

Application Number Title Priority Date Filing Date
TW092127679A TWI295671B (en) 2002-10-07 2003-10-06 Tricyclic tetrahydroquinoline antibacterial agents

Country Status (16)

Country Link
US (4) US7208490B2 (enExample)
EP (1) EP1551849B1 (enExample)
JP (1) JP4009652B2 (enExample)
AR (1) AR041546A1 (enExample)
AT (1) ATE473985T1 (enExample)
AU (1) AU2003264768A1 (enExample)
BR (1) BR0315139A (enExample)
CA (1) CA2500824C (enExample)
CY (1) CY1110821T1 (enExample)
DE (1) DE60333379D1 (enExample)
DK (1) DK1551849T3 (enExample)
MX (1) MXPA05002701A (enExample)
PT (1) PT1551849E (enExample)
SI (1) SI1551849T1 (enExample)
TW (1) TWI295671B (enExample)
WO (1) WO2004031195A1 (enExample)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7208490B2 (en) 2002-10-07 2007-04-24 Pharmacia & Upjohn Company Llc Tricyclic tetrahydroquinoline antibacterial agents
JP2008543739A (ja) * 2005-05-09 2008-12-04 ワーナー−ランバート カンパニー リミテッド ライアビリティー カンパニー 抗菌剤
DOP2006000268A (es) * 2005-12-22 2007-07-31 Pfizer Prod Inc Agentes antibacterianos
CN101784553A (zh) * 2007-07-02 2010-07-21 阿斯利康(瑞典)有限公司 3-螺嘧啶三酮-喹啉衍生物及其作为抗菌药物的应用
RU2010105007A (ru) 2007-07-16 2011-08-27 Астразенека Аб (Se) Химические соединения
AU2009305203B2 (en) * 2008-10-14 2013-03-07 Entasis Therapeutics Limited Fused, spirocyclic heteroaromatic compounds for the treatment of bacterial infections
US9040528B2 (en) 2008-10-14 2015-05-26 Astrazeneca Ab Chemical compounds 542
WO2010075380A1 (en) * 2008-12-23 2010-07-01 Abbott Laboratories Anti-viral compounds
BR112013001138A2 (pt) 2010-07-16 2016-07-05 Abbvie Inc ligantes de fosfina para reações catalíticas
US8975443B2 (en) 2010-07-16 2015-03-10 Abbvie Inc. Phosphine ligands for catalytic reactions
WO2012009699A2 (en) 2010-07-16 2012-01-19 Abbott Laboratories Process for preparing antiviral compounds
US9255074B2 (en) 2010-07-16 2016-02-09 Abbvie Inc. Process for preparing antiviral compounds
RU2644250C2 (ru) * 2012-09-14 2018-02-08 Элизабет ЛЕВИНА Лекарственное средство с активностью против грамположительных бактерий, микобактерий и грибов
US8952149B2 (en) 2012-09-26 2015-02-10 Zoetis Llc Tricyclic tetrahydroquinoline antibacterial agents
US8889671B2 (en) 2013-01-23 2014-11-18 Astrazeneca Ab Compounds and methods for treating bacterial infections
JP6156845B2 (ja) * 2014-03-04 2017-07-05 株式会社島津製作所 マトリックス支援レーザ脱離イオン化質量分析用マトリックス
EA033459B1 (ru) 2014-05-29 2019-10-31 Entasis Therapeutics Ltd Конденсированные спироциклические гетероароматические соединения для лечения бактериальных инфекций
WO2017156519A1 (en) 2016-03-11 2017-09-14 The Board Of Trustees Of The University Of Illinois Small-molecules active against gram-negative bacteria
US11274106B2 (en) 2017-06-23 2022-03-15 The Board Of Trustees Of The University Of Illinois Topoisomerase inhibitors with antibacterial and anticancer activity
CN108101860B (zh) * 2018-02-08 2021-11-23 苏州敬业医药化工有限公司 顺式-2,6-二甲基吗啉的制备方法
CN115466212B (zh) * 2022-10-26 2023-09-22 河南农业大学 一种2-三氟甲基喹啉类化合物及其合成方法和应用
CN118878546B (zh) * 2024-09-30 2025-01-03 苏州大学 一种螺环巴比妥酸衍生物及其制备方法和应用

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5011860A (en) 1986-04-11 1991-04-30 Schering Corporation Aryl-substituted naphthyridine and pyridopyrazine derivatives and their use in treating hyperproliferative skin diseases
DE19502178A1 (de) 1994-01-27 1995-08-03 Hoechst Ag Thiadiazolderivate, Verfahren zu ihrer Herstellung und ihre Verwendung als Vorprodukte zur Herstellung von Flüssigkristallen
CA2425283A1 (en) 2000-10-26 2002-05-02 Pfizer Products Inc. Spiro-pyrimidine-2,4,6-trione metalloproteinase inhibitors
WO2003091252A1 (en) 2002-04-25 2003-11-06 Bristol-Myers Squibb Company Spirobarbituric acid derivatives useful as inhibitors of matrix metalloproteases
US7208490B2 (en) 2002-10-07 2007-04-24 Pharmacia & Upjohn Company Llc Tricyclic tetrahydroquinoline antibacterial agents
MXPA05003774A (es) 2002-10-10 2005-06-08 Pharmacia & Upjohn Co Llc Compuestos de 1-aril-dihidropiridona con actividad antimicrobiana.

Also Published As

Publication number Publication date
US7605157B2 (en) 2009-10-20
AR041546A1 (es) 2005-05-18
JP4009652B2 (ja) 2007-11-21
US7208490B2 (en) 2007-04-24
SI1551849T1 (sl) 2010-11-30
DK1551849T3 (da) 2010-10-25
ATE473985T1 (de) 2010-07-15
CA2500824C (en) 2011-03-22
US20070161630A1 (en) 2007-07-12
EP1551849A1 (en) 2005-07-13
EP1551849B1 (en) 2010-07-14
US20110092494A1 (en) 2011-04-21
CA2500824A1 (en) 2004-04-15
BR0315139A (pt) 2005-08-09
WO2004031195A1 (en) 2004-04-15
PT1551849E (pt) 2010-09-27
US20040162279A1 (en) 2004-08-19
AU2003264768A1 (en) 2004-04-23
JP2006511595A (ja) 2006-04-06
US20100022524A1 (en) 2010-01-28
DE60333379D1 (de) 2010-08-26
CY1110821T1 (el) 2015-06-10
TW200413394A (en) 2004-08-01
US8420646B2 (en) 2013-04-16
MXPA05002701A (es) 2005-08-19

Similar Documents

Publication Publication Date Title
US11479551B2 (en) MTA-cooperative PRMT5 inhibitors
AU2012300844B2 (en) Substituted annellated pyrimidine and the use thereof
US11787796B2 (en) Plasma Kallikrein inhibitors and uses thereof
CN102834393B (zh) 细胞凋亡信号调节激酶1抑制剂
EP2575473B1 (en) Soluble guanylate cyclase activators
ES2729630T3 (es) Compuestos heteroaromáticos y su uso como ligandos de dopamina D1
ES2360222T3 (es) Agentes policíclicos para el tratamiento de infecciones respiratorias por virus sincicial.
TW201211038A (en) Oxazine derivatives and their use in the treatment of neurological disorders
TW200413394A (en) Tricyclic tetrahydroquinoline antibacterial agents
TW201718493A (zh) 作為magl抑制劑的胺基甲酸1,1,1-三氟-3-羥基丙烷-2-基酯衍生物及胺基甲酸1,1,1-三氟-4-羥基丁烷-2-基酯衍生物
TW201026686A (en) Heterobicyclic carboxamides as inhibitors for kinases
TW201247675A (en) Tricyclic inhibitors of kinases
US20140350020A1 (en) Ring-fused pyrimidines and triazines and use thereof for the treatment and/or prophylaxis of cardiovascular diseases
TW201321375A (zh) 作為突變idh之抑制劑之3-嘧啶-4-基-□唑啶-2-酮
AU2019261308B2 (en) Antiproliferation compounds and uses thereof
TW201202246A (en) Heterocyclic compounds as JANUS kinase inhibitors
US11242335B2 (en) Fluorine-substituted indazole compounds and uses thereof
US20200069691A1 (en) Heterocyclic compounds as hiv protease inhibitors
TW200904817A (en) Compounds and uses thereof
CN102844318B (zh) 用于治疗呼吸道合胞病毒感染的化合物
ES2529038T3 (es) Inhibidores de la integrasa de VIH
CN108690016B (zh) 吡唑并吡啶类化合物及其用途
CN113747894A (zh) 成纤维细胞生长因子受体2(fgfr2)的降解剂
TW509692B (en) 2-amino-7-(1-substituted-2-hydroxyethyl)-3,5-dihydro-pyrrolo[3,2-d]pyrimidin-4-ones
CN107108658A (zh) 取代的环状嘧啶及其用途

Legal Events

Date Code Title Description
MM4A Annulment or lapse of patent due to non-payment of fees